New G-RISE and IMSD Funding Announcements and Upcoming Webinar
Funding opportunity announcements (FOAs) for the Graduate Research Training Initiative for Student Enhancement (G-RISE) (PAR-21-026) and the Initiative for Maximizing Student Development (IMSD) (PAR-21-025) T32 programs have been issued. The FOAs continue the shared goal to develop a diverse pool of scientists earning Ph.D. degrees who have the skills necessary to transition successfully into careers in the biomedical research workforce.
The new G-RISE and IMSD FOAs have an application receipt date of February 26, 2021. The earliest start date for both programs is February 2022.
Both FOAs have eliminated the requ...
Source: NIGMS Feedback Loop Blog - National Institute of General Medical Sciences - November 20, 2020 Category: Biomedical Science Authors: Chrissa Chverchko Tags: Funding Opportunities Meetings/Events Training/Fellowships/Career Development Preparing an Application Webinars Source Type: blogs
Being 75 Will Be Great, and the Younger You are Now, the Better It Will Be When You Get There
There is a certain constituency in this world of ours whose members look at the far side of middle age with a fatalistic gloom, envisaging the last, decrepit light before the darkness. The age of 75 stands out in the present discussion on this topic only for a noted op-ed touting a hoped end to life at that point. That voice isn't alone. Many people, perhaps even most people, express the desire to die on some schedule in late life, if asked. Perhaps a few years older than their peers, because hierarchy is important to we primates, but nonetheless, the present view is that after middle age we should be shutting up shop, tid...
Source: Fight Aging! - November 19, 2020 Category: Research Authors: Reason Tags: Activism, Advocacy and Education Source Type: blogs
Funding Opportunity: R21/R33 to Test Existing or New Biospecimens from Sepsis Patients
We’ve issued a new funding opportunity announcement (FOA): Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 – Clinical Trial Not Allowed) (PAR-21-077). This FOA aims to promote the optimal use, testing, and sharing of patient-derived materials. It stems from recommendations of the NAGMSC working group on sepsis and input from the scientific community for strategies to rebalance NIGMS’ investment in sepsis research.
This two-phase FOA supports a 2-year R21 award for up to $275,000 direct costs in the first phase, and a 2-year R33 award with a budget cap of $500...
Source: NIGMS Feedback Loop Blog - National Institute of General Medical Sciences - November 17, 2020 Category: Biomedical Science Authors: Chrissa Chverchko Tags: Funding Opportunities Sepsis Research Source Type: blogs
Thoughts on Our Virtual IDeA Program Meeting
In September, we hosted a virtual meeting for investigators and students supported by the Institutional Development Award (IDeA) program to introduce them to strategic initiatives from NIH leaders in response to COVID-19, and to highlight scientific progress by IDeA researchers. We were pleased with the overwhelming response from the IDeA community—there were approximately 750 attendees and more than 180 abstracts submitted.
Highlights of the meeting included presentations by:
NIH Associate Deputy Director Tara Schwetz, who gave an overview of the Rapid Acceleration of Diagnostics (RADx) initiative and the o...
Source: NIGMS Feedback Loop Blog - National Institute of General Medical Sciences - November 16, 2020 Category: Biomedical Science Authors: Chrissa Chverchko Tags: Meetings/Events Institutional Development Award Research Capacity Building Source Type: blogs
Fight Aging! Newsletter, November 9th 2020
In this study, young adult mice were submitted to endurance exercise training and the function, differentiation, and metabolic characteristics of satellite cells were investigated in vivo and in vitro.
We found that injured muscles from endurance-exercised mice display improved regenerative capacity, demonstrated through higher densities of newly formed myofibres compared with controls (evidenced by an increase in embryonic myosin heavy chain expression), as well as lower inflammation (evidenced by quantifying CD68-marked macrophages), and reduced fibrosis. Enhanced myogenic function was accompanied by an increased ...
Source: Fight Aging! - November 8, 2020 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
